Search the Newsreel

Arista Networks, Inc. $ANET Stock Position Boosted by Smith Group Asset Management LLC

Smith Group Asset Management LLC increased its stake in Arista Networks (ANET) by 7.6% during the second quarter, making it their 9th largest holding. The article also details other institutional investor activity, recent insider stock sales, Arista Networks' financial performance, and current analyst ratings. …

Jennison Associates LLC Has $45.43 Million Stake in Arista Networks, Inc. $ANET

Jennison Associates LLC decreased its stake in Arista Networks (NYSE:ANET) by 4.2% in the second quarter, holding 267,450 shares valued at $45.43 million. Despite this, institutional investors collectively own 82.47% of the company. Arista Networks reported strong quarterly results, with earnings and revenue exceeding …

Arista Networks vs. Intel: Which Technology Stock Is a Better Buy in 2026?

As the artificial intelligence infrastructure boom matures, investors are weighing the rapid growth of Arista Networks (NYSE:ANET) against the turnaround efforts at Intel (NASDAQ:INTC) to see which is the better buy today. Arista provides high-speed networking equipment essential for modern data centers, while Intel …

Assenagon Asset Management S.A. Makes New $1.63 Million Investment in Avista Corporation $AVA

Assenagon Asset Management S.A. has initiated a new $1.63 million investment in Avista Corporation (NYSE:AVA) by purchasing 39,860 shares in the second quarter. This move comes as other institutional investors, such as Goldman Sachs and Northwestern Mutual Wealth Management Co., also significantly increased their …

Arista Networks, Inc. $ANET Stock Holdings Lowered by DSM Capital Partners LLC

DSM Capital Partners LLC decreased its stake in Arista Networks by 2.0% in the second quarter, selling 54,578 shares but still holding 2.63 million shares valued at approximately $447.1 million. The article notes that institutional investors collectively own 82.47% of the company, and despite …

Crew Capital Management Ltd Takes Position in Arista Networks, Inc. $ANET

Crew Capital Management Ltd has acquired a new stake of 7,518 shares in Arista Networks, valued at approximately $1.28 million. Arista Networks reported strong Q2 results with revenue up 37.7% year-over-year and EPS exceeding expectations, driven by AI infrastructure spending. Despite a consensus "Buy" …

NCS Multistage (NASDAQ:NCSM) Share Price Crosses Above Fifty Day Moving Average - Should You Sell?

NCS Multistage (NASDAQ:NCSM) saw its shares rise above their 50-day moving average, reaching $51.69 against an average of $47.42, although trading volume was low. Analyst sentiment leans towards a "Moderate Buy," despite the company missing quarterly earnings expectations with a loss of $1.71 per …

Choreo LLC Acquires 5,343 Shares of Arista Networks, Inc. $ANET

Choreo LLC increased its stake in Arista Networks (ANET) by 21.5% in the second quarter, bringing its total holdings to 30,151 shares valued at $5.12 million. Arista Networks reported strong quarterly earnings of $1.02 per share, exceeding estimates, and revenue of $3.04 billion, a …

Vistagen Therapeutics: Runway To Fund Operations Into 2027 >VTGN

Vistagen Therapeutics (VTGN) announced a non-dilutive financing of up to $100 million with HealthCare Royalty Partners. This agreement extends the company's financial runway into 2027, allowing it to advance its late-stage clinical programs. The initial $50 million will support the Phase 3 PALISADE-2 trial …

Arista Networks, Inc. $ANET Shares Sold by Ascent Group LLC

Ascent Group LLC decreased its stake in Arista Networks (ANET) by 13.6% in the second quarter, selling 21,153 shares but still holding 134,857 shares valued at $22.9 million. This comes as Arista Networks reported strong quarterly earnings, with revenue up 37.7% and EPS of …

Civista Bancshares (NASDAQ:CIVB) Share Price Crosses Above 200 Day Moving Average - What's Next?

Civista Bancshares (NASDAQ:CIVB) recently saw its stock price cross above its 200-day moving average, closing at $28.51 against an average of $25.43. The company has a "Moderate Buy" consensus rating from analysts with an average price target of $30.25, and it exceeded quarterly EPS …

Vistagen Therapeutics (VTGN) flags going concern risk amid Q1 loss and Nasdaq pressure

Vistagen Therapeutics reported a net loss of $13.0 million for Q1 2027, an improvement from the prior year, with revenue increasing to $1.5 million. Despite this, the company flagged substantial doubt about its ability to continue as a going concern due to high operating …

Vista Energy Repurchases 50,000 Series A Shares in August 2026 Buyback

Vista Energy repurchased 50,000 Series A shares on August 14, 2026, for approximately 58.5 million pesos as part of its capital management program. This transaction leaves Vista with over 110.6 million Series A shares outstanding and aims to optimize capital structure and enhance shareholder …

William Blair Maintains VistaGen Therapeutics(VTGN.US) With Hold Rating

William Blair has reiterated its Hold rating for VistaGen Therapeutics (VTGN.US). The report from the investment firm indicates their continued neutral stance on the company's stock.

Precision Trading with Ncs Multistage Holdings Inc. (NCSM) Risk Zones

This article provides a detailed analysis of Ncs Multistage Holdings Inc. (NCSM) using AI models, highlighting strong sentiment across all horizons. It outlines distinct trading strategies for various risk profiles, including long, breakout, and short setups with specific entry zones, targets, and stop losses. …

Comparing Investment in Arista Networks vs IBM

This article compares investment in Arista Networks (ANET) and IBM, highlighting their financial performance, risks, and valuation. Arista Networks demonstrates strong growth in data center solutions with high revenue and net income, but faces customer concentration risks and a high forward P/E ratio. IBM …

La directora ejecutiva de Arista Networks vende acciones por 119,3 millones de dólares

Insider Selling: Arista Networks (NYSE:ANET) CEO Sells 573,509 Shares

Arista Networks CEO Jayshree Ullal sold 573,509 shares of the company's stock for approximately $119.4 million, significantly reducing her direct holdings. This transaction was part of a pre-arranged trading plan, following several other large sales in recent months. Despite the insider selling, Arista Networks …

Arista Networks (ANET) family trusts sell 573,509 shares under 10b5-1 plan

Trusts associated with Arista Networks CEO and Chairperson Jayshree Ullal sold a total of 573,509 shares of common stock on August 12, 2026. These indirect sales, made under a Rule 10b5-1 trading plan, occurred at weighted average prices ranging from $207.00 to $211.37 per …

CIVB Q2 2026 Earnings: EPS Beats Estimates by 10.7% as Shares Edge Lower - Consensus Forecast Report

Vistagen Therapeutics (VTGN): OrbiMed reports 0.0% beneficial ownership in latest 13G/A

Arista Networks (NYSE:ANET) Trading Down 2.3% - Should You Sell?

Arista Networks (NYSE:ANET) shares dropped 2.3% in mid-day trading despite strong quarterly results that beat analyst estimates for EPS and revenue, with 37.7% year-over-year revenue growth. Analysts maintain a "Buy" rating with a consensus target of $226.05, with some firms recently raising their targets. …

Arista Networks (ANET) Is Up 5.9% After AI-Fueled Q3 Revenue Guidance Upgrade - Has The Bull Case Changed?

In the past week, Arista Networks reported second-quarter 2026 results showing revenue of US$3.04 billion and net income of US$1.21 billion, alongside guidance for roughly US$3.30 billion in third-quarter revenue. Management linked this stronger outlook to accelerating demand for AI-driven network deployments, underscoring how …

Arista Networks vs. AppLovin: Which Technology Stock Is a Better Buy in 2026?

This article compares Arista Networks (ANET) and International Business Machines (IBM) as potential technology stock investments in 2026, analyzing their business models, financial performance, risk profiles, and valuations. While Arista Networks operates in data center hardware with high growth and margins but customer concentration, …

Arista Networks vs. AppLovin: Which High-Growth Tech Stock Deserves Your Capital in 2026?

This article compares Arista Networks and AppLovin as high-growth tech stock investment opportunities in 2026, highlighting their differing approaches to the AI boom. Arista Networks offers stability and strong cash flow through data center infrastructure, despite customer concentration risks. AppLovin, while showing higher growth …

Arista Networks Inc. stock underperforms Friday when compared to competitors

Shares of Arista Networks Inc. (ANET) fell 2.36% on Friday, closing at $198.82, underperforming the broader market. This decline occurred during a poor trading session where the S&P 500 Index dropped 0.17% and the Dow Jones Industrial Average fell 0.20%. This marks the second …

Cinevista Ltd Reports Very Positive Financial Trend Amid Margin Expansion

Vistagen Therapeutics (VTGN) investor Chen Yu reports 6.7% warrant-based stake

Chen Yu, through TCG Crossover funds, has reported a 6.7% warrant-based stake in Vistagen Therapeutics (VTGN) via an amended Schedule 13G/A filing. TCG Crossover I holds 1.8% and TCG Crossover II holds 5.1%, with Chen Yu being the sole managing member of both general …

Vistagen Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026

Vistagen (VTGN) narrows quarterly loss, eyes FDA path after mixed fasedienol data

Vistagen (VTGN) reported a narrower net loss of $13.0 million for Q1 FY2027, an improvement from $15.1 million in the prior-year quarter, largely due to increased revenue and reduced R&D and G&A expenses. While its lead drug fasedienol missed its primary endpoint in the …

VistaGen Therapeutics earnings missed by $0.05, revenue topped estimates

Vistagen Therapeutics Releases Q1 2027 Financial Results

Vistagen Therapeutics reported a narrower loss for Q1 fiscal 2027, with a basic and diluted loss of $0.30 per share and a net loss of $13.0M. The company saw a significant revenue increase to $1.5M, up 504.9% year-over-year, as it continues to develop therapies …

Vistagen Reports Narrower Q1 Loss; Plans FDA Meeting On Fasedienol Development Path

(RTTNews) - Vistagen Therapeutics Inc. (VTGN), a late clinical-stage biopharmaceutical company developing intranasal pherine therapies for neuropsychiatric and other disorders, reported first quarter fiscal 2027 results and provided a corporate update. Vistagen is developing rapid-onset intranasal pherine product candidates designed to target nose-to-brain neurocircuitry. …

Can NVST Sustain Its 2026 Guidance Boost as Margins Keep Expanding?

Envista Holdings Corporation NVST raised its 2026 outlook after a stronger first half, putting greater emphasis on whether recent sales and profit gains can carry through the rest of the year. Higher revenue expectations and expanding margins support the earnings recovery. China pricing changes, …

Vistagen reports Q1 FY2027: $1.48M revenue, $13.0M net loss, $31.7M cash at June 30, 2026

Vistagen announced its Q1 FY2027 results, reporting $1.476 million in revenue and a net loss of $13.03 million. The company ended the quarter with $31.7 million in cash, expecting these funds to support operations into 2027. Vistagen also highlighted upcoming FDA discussions regarding a …

Form 8K VistaGen Therapeutics Inc For: 14 August By Investing.com

This article announces that VistaGen Therapeutics Inc. has filed a Form 8K on August 14th. The brief news item from Investing.com provides no further details about the content of the filing but notes the stock symbol VTGN.